Clinical impact of enhanced cytokine clearance with sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in patients with severe sepsis

Documenti analoghi

• Sustained high-efficiency daily diafiltration using a cytokine-adsorbing membrane in the treatment of patients with severe sepsis
  di: Nishida, O, et al.
  Pubblicazione: (2011)
• Extracorporeal membrane oxygenation: the MOTOR of cytokine production?
  di: Hara, Y, et al.
  Pubblicazione: (2013)
• In vitro evaluation of HMGB1 removal with various membranes for continuous hemofiltration
  di: Yumoto, M, et al.
  Pubblicazione: (2011)
• Treatment of critically ill children with kidney injury by sustained low-efficiency daily diafiltration
  di: Lee, Chia-Ying, et al.
  Pubblicazione: (2012)
• Sustained Low-Efficiency Daily Diafiltration for Diabetic Nephropathy Patients with Acute Kidney Injury
  di: Chen, Xinghua, et al.
  Pubblicazione: (2014)